• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证偏头痛特异性生活质量问卷 v2.1(MSQ)在意大利慢性偏头痛伴药物过度使用史住院患者中的适用性。

Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.

机构信息

Neurology, Public Health and Disability Unit, Neurological Institute C. Besta IRCCS Foundation, Via Celoria 11, 20133, Milan, Italy,

出版信息

Qual Life Res. 2014 May;23(4):1273-7. doi: 10.1007/s11136-013-0556-9. Epub 2013 Oct 16.

DOI:10.1007/s11136-013-0556-9
PMID:24129671
Abstract

PURPOSE

The purpose of the study is to assess validity, reliability and factor structure of the Italian version of Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in patients suffering from chronic migraine (CM) with a history of medication overuse (MO).

METHODS

Patients were enrolled at hospital admission for withdrawal from MO. Factor analysis was used to confirm the latent structure of the MSQ. Reliability was measured with Cronbach's alpha coefficient, item-total correlation and inter-item correlation. Construct validity was assessed with Pearson's coefficient and known-group analysis.

RESULTS

The three-factor structure is basically confirmed. Cronbach's alpha varied between 0.85 and 0.92; item-total correlations were on average higher than 0.70; average inter-item correlation ranged between 0.63 and 0.65. Correlations were all significant; known-group analysis shows that MSQ score was lower consistently with disease severity.

CONCLUSIONS

Our findings confirm the factor structure, reliability and validity of the MSQ and expand results of previous validation studies to the Italian language and to a group of patients with severe CM requiring withdrawal treatment for MO.

摘要

目的

本研究旨在评估有药物过度使用史的慢性偏头痛(CM)患者使用偏头痛特异性生活质量问卷 2.1 版(MSQ)意大利语版的效度、信度和因子结构。

方法

患者在入院接受药物戒断治疗时入组。采用因子分析来确认 MSQ 的潜在结构。采用 Cronbach's alpha 系数、条目-总分相关性和条目间相关性来衡量信度。采用 Pearson 系数和已知组分析评估结构效度。

结果

基本证实了三因素结构。Cronbach's alpha 在 0.85 到 0.92 之间;条目-总分相关性平均高于 0.70;平均条目间相关性在 0.63 到 0.65 之间。相关性均有统计学意义;已知组分析表明,MSQ 评分随着疾病严重程度的增加而持续降低。

结论

本研究结果证实了 MSQ 在意大利语和一组需要接受药物戒断治疗的严重 CM 患者中的因子结构、信度和效度。

相似文献

1
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.验证偏头痛特异性生活质量问卷 v2.1(MSQ)在意大利慢性偏头痛伴药物过度使用史住院患者中的适用性。
Qual Life Res. 2014 May;23(4):1273-7. doi: 10.1007/s11136-013-0556-9. Epub 2013 Oct 16.
2
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.验证偏头痛特异性生活质量问卷 v2.1 在发作性和慢性偏头痛中的适用性。
Headache. 2012 Mar;52(3):409-21. doi: 10.1111/j.1526-4610.2011.01997.x. Epub 2011 Sep 19.
3
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients.偏头痛特异性生活质量问卷 2.1 版(MSQ)在慢性偏头痛患者中的心理测量特性。
Qual Life Res. 2013 Jun;22(5):1123-33. doi: 10.1007/s11136-012-0230-7. Epub 2012 Jul 15.
4
Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).希腊偏头痛特异性生活质量问卷(MSQ 版本 2.1-GR)的有效性和可靠性。
J Patient Rep Outcomes. 2024 Jul 15;8(1):72. doi: 10.1186/s41687-024-00762-4.
5
Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.偏头痛特异性生活质量问卷 2.1 电子患者报告结局在发作性和慢性偏头痛患者中的心理测量验证和有意义的患者内变化。
Headache. 2021 Mar;61(3):511-526. doi: 10.1111/head.14031. Epub 2021 Jan 22.
6
Quality of life measures in Italian neurosurgical patients: validity of the EUROHIS-QOL 8-item index.意大利神经外科患者的生活质量测量:EUROHIS-QOL 8项指标的有效性
Qual Life Res. 2015 Feb;24(2):441-4. doi: 10.1007/s11136-014-0784-7. Epub 2014 Aug 23.
7
The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines.波斯语偏头痛特异性生活质量问卷2.1版在发作性和慢性偏头痛中的心理测量特性。
ScientificWorldJournal. 2013 Aug 27;2013:950245. doi: 10.1155/2013/950245. eCollection 2013.
8
Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.偏头痛特异性生活质量问卷2.1版(MSQ v. 2.1)在接受偏头痛预防性治疗患者中的效度验证。
Qual Life Res. 2007 Sep;16(7):1231-7. doi: 10.1007/s11136-007-9217-1. Epub 2007 Apr 28.
9
Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine.偏头痛特异性生活质量问卷中文修订版 2.1 版(MSQv2.1-C):偏头痛患者的心理测量评估。
Health Qual Life Outcomes. 2019 Jun 24;17(1):108. doi: 10.1186/s12955-019-1169-y.
10
Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).偏头痛特异性生活质量问卷(MSQ 2.1版)的效度与信度。
Headache. 2000 Mar;40(3):204-15. doi: 10.1046/j.1526-4610.2000.00030.x.

引用本文的文献

1
Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).希腊偏头痛特异性生活质量问卷(MSQ 版本 2.1-GR)的有效性和可靠性。
J Patient Rep Outcomes. 2024 Jul 15;8(1):72. doi: 10.1186/s41687-024-00762-4.
2
Multimodal digital health treatments for Chronic Migraine associated with Medication Overuse Headache: a literature appraisal and results of a single-arm open trial (the BE-HOME program).多模态数字化健康治疗慢性偏头痛伴药物过度使用性头痛:文献评价和单臂开放试验结果(BE-HOME 项目)。
Neurol Sci. 2024 Oct;45(10):4923-4930. doi: 10.1007/s10072-024-07568-8. Epub 2024 May 21.
3

本文引用的文献

1
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients.偏头痛特异性生活质量问卷 2.1 版(MSQ)在慢性偏头痛患者中的心理测量特性。
Qual Life Res. 2013 Jun;22(5):1123-33. doi: 10.1007/s11136-012-0230-7. Epub 2012 Jul 15.
2
Disability and mood state in patients with episodic and chronic migraine associated to medication overuse.药物过度使用性头痛相关的发作性和慢性偏头痛患者的残疾和情绪状态。
Neurol Sci. 2012 May;33 Suppl 1:S169-71. doi: 10.1007/s10072-012-1076-z.
3
The cost of headache disorders in Europe: the Eurolight project.
Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study).
正念疗法联合常规治疗对慢性偏头痛和药物过度使用性头痛患者的疗效:一项 III 期单盲随机对照试验(MIND-CM 研究)。
J Headache Pain. 2023 Jul 14;24(1):86. doi: 10.1186/s10194-023-01630-0.
4
Withdrawal failure in patients with chronic migraine and medication overuse headache.慢性偏头痛和药物过度使用性头痛患者的撤药失败。
Acta Neurol Scand. 2021 Oct;144(4):408-417. doi: 10.1111/ane.13475. Epub 2021 May 25.
5
The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries.欧洲偏头痛的人文和经济负担:五个国家的横断面调查
Neurol Ther. 2020 Dec;9(2):535-549. doi: 10.1007/s40120-020-00196-2. Epub 2020 Jun 15.
6
Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.评估非药物干预在频繁发作性或慢性偏头痛中有效性的结局指标:一项德尔菲研究。
BMJ Open. 2020 Feb 12;10(2):e029855. doi: 10.1136/bmjopen-2019-029855.
7
Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine.偏头痛特异性生活质量问卷中文修订版 2.1 版(MSQv2.1-C):偏头痛患者的心理测量评估。
Health Qual Life Outcomes. 2019 Jun 24;17(1):108. doi: 10.1186/s12955-019-1169-y.
8
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire.验证一种用于评估偏头痛患者与工作相关困难的自我报告工具:HEADWORK 问卷。
J Headache Pain. 2018 Sep 10;19(1):85. doi: 10.1186/s10194-018-0914-7.
9
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.欧洲偏头痛患者负担的患者视角:法国、德国、意大利、西班牙和英国的调查数据分析。
J Headache Pain. 2018 Sep 10;19(1):82. doi: 10.1186/s10194-018-0907-6.
10
Clinical and psychosocial features of frequent relapsers (FR) among patients with chronic migraine and medication overuse.慢性偏头痛和药物过度使用患者中频繁复发者的临床和社会心理特征
Neurol Sci. 2017 May;38(Suppl 1):169-171. doi: 10.1007/s10072-017-2894-9.
欧洲头痛障碍的成本:Eurolight 项目。
Eur J Neurol. 2012 May;19(5):703-11. doi: 10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.
4
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.肉毒毒素 A 能提高生活质量,降低慢性偏头痛的影响。
Neurology. 2011 Oct 11;77(15):1465-72. doi: 10.1212/WNL.0b013e318232ab65. Epub 2011 Sep 28.
5
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.验证偏头痛特异性生活质量问卷 v2.1 在发作性和慢性偏头痛中的适用性。
Headache. 2012 Mar;52(3):409-21. doi: 10.1111/j.1526-4610.2011.01997.x. Epub 2011 Sep 19.
6
Disability in chronic daily headache: state of the art and future directions.慢性每日头痛中的残疾:现状与未来方向。
Neurol Sci. 2011 May;32 Suppl 1:S71-6. doi: 10.1007/s10072-011-0552-1.
7
Migraine chronification.偏头痛慢性化。
Curr Neurol Neurosci Rep. 2011 Apr;11(2):139-48. doi: 10.1007/s11910-010-0175-6.
8
Developing the World Health Organization Disability Assessment Schedule 2.0.制定世界卫生组织残疾评估表 2.0。
Bull World Health Organ. 2010 Nov 1;88(11):815-23. doi: 10.2471/BLT.09.067231. Epub 2010 May 20.
9
Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version.偏头痛特异性生活质量问卷(MSQ)版本中的最小重要差异。
Cephalalgia. 2009 Nov;29(11):1180-7. doi: 10.1111/j.1468-2982.2009.01852.x.
10
Global prevalence of chronic migraine: a systematic review.全球慢性偏头痛患病率:系统评价。
Cephalalgia. 2010 May;30(5):599-609. doi: 10.1111/j.1468-2982.2009.01941.x.